  We consider designs for cancer trials which allow each medical centre to
treat only a limited number of cancer types with only a limited number of
drugs. We specify desirable properties of these designs, and prove some
consequences. Then we give several different constructions. Finally we
generalise this to three or more types of object, such as biomarkers.
